CHRM2 and diabetes mellitus: The increased inhibition of acetylcholine release by inhibitory neuronal M2 muscarinic receptors during experimental diabetes has been described extensively in different experimental models, including rat lungs [16], the ileum and trachea from diabetic rats [18], the urinary bladder [38], and even in human cardiac atrium [39].